EE200300413A - Taksaani metronoomiline annustamisskeem ning meetod kasvajarakkude kasvu pärssimiseks - Google Patents

Taksaani metronoomiline annustamisskeem ning meetod kasvajarakkude kasvu pärssimiseks

Info

Publication number
EE200300413A
EE200300413A EEP200300413A EEP200300413A EE200300413A EE 200300413 A EE200300413 A EE 200300413A EE P200300413 A EEP200300413 A EE P200300413A EE P200300413 A EEP200300413 A EE P200300413A EE 200300413 A EE200300413 A EE 200300413A
Authority
EE
Estonia
Prior art keywords
taxane
cell growth
tumor cell
dosing regimen
inhibiting tumor
Prior art date
Application number
EEP200300413A
Other languages
English (en)
Estonian (et)
Inventor
Fargnoli Joseph
C. Rose William
Trail Pamela
Original Assignee
Bristol-Myers Squibb Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company filed Critical Bristol-Myers Squibb Company
Publication of EE200300413A publication Critical patent/EE200300413A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Carpets (AREA)
EEP200300413A 2001-02-28 2002-02-26 Taksaani metronoomiline annustamisskeem ning meetod kasvajarakkude kasvu pärssimiseks EE200300413A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27194401P 2001-02-28 2001-02-28
PCT/US2002/005971 WO2002067928A2 (en) 2001-02-28 2002-02-26 Metronomic dosing of taxanes for inhibiting tumor growth

Publications (1)

Publication Number Publication Date
EE200300413A true EE200300413A (et) 2003-12-15

Family

ID=23037749

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300413A EE200300413A (et) 2001-02-28 2002-02-26 Taksaani metronoomiline annustamisskeem ning meetod kasvajarakkude kasvu pärssimiseks

Country Status (31)

Country Link
EP (1) EP1372636B1 (sk)
JP (1) JP2004538253A (sk)
KR (1) KR20030086276A (sk)
CN (1) CN1533273A (sk)
AR (1) AR033609A1 (sk)
AT (1) ATE331511T1 (sk)
BG (1) BG108167A (sk)
BR (1) BR0207519A (sk)
CA (1) CA2439299A1 (sk)
CY (1) CY1105468T1 (sk)
CZ (1) CZ20032232A3 (sk)
DE (2) DE02723255T1 (sk)
DK (1) DK1372636T3 (sk)
EE (1) EE200300413A (sk)
ES (1) ES2211374T3 (sk)
HR (1) HRP20030775A2 (sk)
HU (1) HUP0402115A2 (sk)
IL (1) IL157356A0 (sk)
IS (1) IS6924A (sk)
MX (1) MXPA03007655A (sk)
NO (1) NO20033809L (sk)
PE (1) PE20020955A1 (sk)
PL (1) PL373376A1 (sk)
PT (1) PT1372636E (sk)
RU (1) RU2003129233A (sk)
SK (1) SK10332003A3 (sk)
TR (1) TR200400375T3 (sk)
UY (1) UY27185A1 (sk)
WO (1) WO2002067928A2 (sk)
YU (1) YU66603A (sk)
ZA (1) ZA200306450B (sk)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750246B1 (en) 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
EP2286794B8 (en) * 2003-10-15 2016-06-01 SynCore Biotechnology CO., LTD Use of cationic liposomes comprising paclitaxel
EP1896007B1 (en) 2005-05-04 2014-03-19 Medigene AG Method of administering a cationic liposomal preparation comprising paclitexel
MX2008011978A (es) 2006-03-22 2009-04-22 Medigene Ag Tratamiento del cancer de seno negativo al triple receptor.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL337064A1 (en) * 1997-05-27 2000-07-31 Baker Norton Pharma Method of and compositions for orally administering taxanes to human beings
US6750246B1 (en) * 2000-02-03 2004-06-15 Bristol-Myers Squibb Company C-4 carbonate taxanes
US6362217B2 (en) * 2000-03-17 2002-03-26 Bristol-Myers Squibb Company Taxane anticancer agents

Also Published As

Publication number Publication date
CN1533273A (zh) 2004-09-29
BG108167A (en) 2004-09-30
WO2002067928A2 (en) 2002-09-06
EP1372636A2 (en) 2004-01-02
UY27185A1 (es) 2002-09-30
HRP20030775A2 (en) 2005-02-28
EP1372636B1 (en) 2006-06-28
DE60212813T2 (de) 2007-01-18
RU2003129233A (ru) 2005-02-10
KR20030086276A (ko) 2003-11-07
IS6924A (is) 2003-08-22
MXPA03007655A (es) 2003-12-04
NO20033809D0 (no) 2003-08-27
ES2211374T1 (es) 2004-07-16
BR0207519A (pt) 2005-03-08
ES2211374T3 (es) 2007-03-01
CA2439299A1 (en) 2002-09-06
DE02723255T1 (de) 2004-07-15
JP2004538253A (ja) 2004-12-24
DK1372636T3 (da) 2006-11-06
TR200400375T3 (tr) 2004-04-21
WO2002067928A3 (en) 2003-10-09
HUP0402115A2 (hu) 2005-02-28
NO20033809L (no) 2003-10-23
PL373376A1 (en) 2005-08-22
CZ20032232A3 (en) 2004-06-16
YU66603A (sh) 2006-08-17
DE60212813D1 (de) 2006-08-10
SK10332003A3 (sk) 2005-03-04
ATE331511T1 (de) 2006-07-15
ZA200306450B (en) 2004-11-19
CY1105468T1 (el) 2010-04-28
PT1372636E (pt) 2006-09-29
PE20020955A1 (es) 2002-10-30
IL157356A0 (en) 2004-02-19
AR033609A1 (es) 2003-12-26

Similar Documents

Publication Publication Date Title
EP1460414A4 (en) CONCENTRATION MEASURING METHOD
DE60217458D1 (de) Massenspektrometer und Verfahren
HK1073722A1 (en) Direct chip attach structure and method
EP1378520A4 (en) TRISPICIFIC ANTIBODY WITH CYCLIC SINGLE STRAND
IL175647A0 (en) Composition and method for enhancing bioavailability
ATE471931T1 (de) Verbindungen, zusammensetzungen und verfahren
EP1694301A4 (en) METHOD AND COMPOSITIONS FOR THE PRODUCTION OF MONOCLONAL ANTIBODIES
EP1496354A4 (en) METHOD FOR DETERMINING SUBSTRATE
DE602004013131D1 (de) Spielautomat, spielmethode und programm
EE200300413A (et) Taksaani metronoomiline annustamisskeem ning meetod kasvajarakkude kasvu pärssimiseks
DE60230823D1 (de) L-cystein herstellendes Bakterium und Verfahren zur Herstellung von L-cystein
NO20040732L (no) Slagmatte for golf
AU2003285066A8 (en) Dosage forms containing stabilized choline and method for preparing same
GB0509662D0 (en) 3-5 group compound semiconductor and method for preparation thereof
ITGE20030109A1 (it) Impianto per la distribuzione di articoli e metodo per
DE60311273D1 (de) Gemischtes schmuckset
AU2003297181A8 (en) Compositions and methods for inhibiting tumor growth and metastasis
PL352959A1 (en) Method of obtaining derivatives of taxane
SI1372636T1 (sl) Metronomsko odmerjanje taksanov za inhibiranje tumorske rasti
FI5678U1 (fi) Kantopakkaus ja kantoelin
ITMI20020303V0 (it) Confezione per pubblicazioni editoriali giochi e simili
SE0101110D0 (sv) Anläggning för genomförande av spel med ett flertal spelare
SE0201603D0 (sv) Player meter
SE0202220L (sv) Infusion container and method for producing the same
PL351692A1 (en) Method of validating measurements